BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). BioLife Solutions's Average Total Inventories for the three months ended in Dec. 2023 was $43.4 Mil. BioLife Solutions's Cost of Goods Sold for the three months ended in Dec. 2023 was $23.5 Mil. Hence, BioLife Solutions's Days Inventory for the three months ended in Dec. 2023 was 168.66.
The historical rank and industry rank for BioLife Solutions's Days Inventory or its related term are showing as below:
During the past 13 years, BioLife Solutions's highest Days Inventory was 301.69. The lowest was 80.15. And the median was 155.55.
BioLife Solutions's Days Inventory increased from Dec. 2022 (103.41) to Dec. 2023 (168.66). It might indicate that BioLife Solutions's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year. BioLife Solutions's Inventory Turnover for the three months ended in Dec. 2023 was 0.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioLife Solutions's Inventory-to-Revenue for the three months ended in Dec. 2023 was 1.33.
The historical data trend for BioLife Solutions's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 301.69 | 199.54 | 88.79 | 106.94 | 148.16 |
BioLife Solutions Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 103.41 | 146.98 | 132.62 | 173.69 | 168.66 |
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioLife Solutions's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (34.904 | + | 43.456) | / | 2 ) | / | 96.519 | * | 365 |
= | 39.18 | / | 96.519 | * | 365 | ||||
= | 148.16 |
BioLife Solutions's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (43.354 | + | 43.456) | / | 2 ) | / | 23.483 | * | 365 / 4 |
= | 43.405 | / | 23.483 | * | 365 / 4 | ||||
= | 168.66 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions (NAS:BLFS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioLife Solutions's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 23.483 | / | 43.405 | |
= | 0.54 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioLife Solutions's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 43.405 | / | 32.733 | |
= | 1.33 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of BioLife Solutions's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Geraint Phillips | officer: SVP, Global Operations | 3303 MONTE VILLA, #310, BOTHELL WA 98021 |
Sarah Aebersold | officer: VP, Global Human Resources | BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Troy Wichterman | officer: Chief Financial Officer | 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Greef Roderick De | director | |
Aby J. Mathew | officer: Chief Tech. Officer & Sr. VP | 3303 MONTE VILLA PARKWAY, #310, BOTHELL WA 98021 |
Todd Berard | officer: Vice President, Marketing | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Karen A. Foster | officer: Vice President of Operations | C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Michael Rice | director, officer: President & CEO | C/O BIOLIFE SOLUTIONS, INC., 171 FRONT STREET, OWEGO NY 13827 |
Casdin Partners Master Fund, L.p. | 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Garrie Richardson | officer: Chief Revenue Officer | 3303 MONTE VILA PARKWAY, BOTHELL WA 98021 |
Marcus Schulz | officer: Vice President, Global Sales | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Joseph C Schick | director | 16719 NE 139TH PLACE, WOODINVILLE WA 98072 |
Amy Duross | director | 8410 GOLDEN BEAR PLACE, WHISTLER A1 V8E 1J7 |
Timothy L. Moore | director | C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404 |
Joydeep Goswami | director | SUMITOMO FUDOSAN MITA TWIN BLDG, EAST WING 4-2-8 SHIBAURA MINATO-KU, TOKYO M0 1080023 |
From GuruFocus
By GuruFocus Research GuruFocus Editor • 12-31-2022
By GuruFocus Research GuruFocus Editor • 05-18-2023
By PRNewswire PRNewswire • 01-17-2023
By PRNewswire • 08-08-2023
By PRNewswire PRNewswire • 06-09-2022
By PRNewswire PRNewswire • 03-01-2023
By PRNewswire PRNewswire • 06-06-2023
By PRNewswire PRNewswire • 06-14-2023
By PRNewswire PRNewswire • 06-29-2022
By GuruFocus Research GuruFocus Editor • 05-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.